WebTV: Market commentary, news and updates from Investtech. See scheduled courses and webinars on the Insight & Skills pages! AnalysisNews. The best

”This is wonderful news, and we are incredibly happy. We are now looking forward to seeing this paper published. The size of the study is

The platform constitutes the communication and distribution platform for Episurf Medical's orthopaedic product line, where medical imaging constitutes a central part. New US patent approval for Episurf Medical within 3D visualisation Tue, Feb 02, 2021 09:45 CET. Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). In recent months, two peer-reviewed publications about the Episealer® have been published, including well over 100 patients in total. These publications constitute significant milestones for Episurf Medical, and we are very pleased with the strong clincial results. Company profile page for Episurf Medical AB including stock price, company news, press releases, executives, board members, and contact information Veronica Wallin, born 1986, has since 2017 worked as CFO at the medical technology company Episurf Medical AB. This information was brought to you by Cision https://news.cision.com. Pål Ryfors, CEO Episurf Medical We are happy to announce the 3 rd edition of the Episealer ® Masterclass Join us on 13-14 June 2019 in central Stockholm to interact with a distinguished faculty, to understand more about our Episealer technology and how this is changing the lives of cartilage patients today. Episurf Medical is a Swedish medical technology company, the first in the world to offer patient-specific implants and surgical instruments for the treatment of painful joint injuries.

Publicerad: 2021-01-27 (Cision) Tisdag Presentation från Episurf Medical Capital Markets Day, Stockholm, 15 september 2020 . Under kapitalmarknadsdagen presenterade Episurfs ledningsgrupp, nyckelkunder och samarbetspartners olika delar av verksamheten. Samtliga presentationer finns tillgängliga via länken. New US patent approval for Episurf Medical within 3D visualisation Tue, Feb 02, 2021 09:45 CET. Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). Episurf Medical - Health Care - Analysguiden. Prenumerera på Episurf Medical.

The surgery itself is well supported by a properly designed 'Final Design' document and an Episurf representative present.

Episurf Medical (Nasdaq: EPIS B) meddelar idag att bolaget utsett Siaca Medical PTY Ltd (https://

Senaste nyheter om - Episurf Medical, aktieanalys, kursutveckling och rapporter. Episurf Medical komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här.

Information on stock, financials, earnings, subsidiaries, investors, and executives for Episurf Medical. Use the PitchBook Platform to explore the full profile.

The best share price. View recent trades and share price information for Episurf Medical AB NPV B. News and fundamental data provided by Digital Look. Exchange 8 Oct 2018 The Episealer implant from Episurf is a custom-made focal resurfacing implant designed to treat focal articular cartilage defects in the knee. With the addition of the EpiGuide® MOS, Episurf Medical expands its product portfolio to include a patient specific precision tool kit for the mosaicplasty procedure, EpiSurf TRial INformation.

Episurf Medical was founded in 2009 and develops and commercialises patient-specific medical devices for the treatment of painful joint injuries.
Elisabeth samuelsson liu

Information on stock, financials, earnings, subsidiaries, investors, and executives for Episurf Medical. Use the PitchBook Platform to explore the full profile.

New US patent approval for Episurf Medical 2021-04-01 10:00:00 Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO).
Registration register

Starting with a special diagnostic MRI, we first discussed the indications with the Episurf Medical team. After a positive decision, the patient was informed and the production process of the individualised implant initiated. The surgery itself is well supported by a properly designed 'Final Design' document and an Episurf representative present.

See scheduled courses and webinars on the Insight & Skills pages! AnalysisNews. The best Episurf Medical (Nasdaq: EPIS B) meddelar idag att posterpresentationen "Clinical results of a patient-specific mini-metal implant for focal… Regulatoriska 8 apr 22 Apr 21. Poster with 5-years' follow-up data presented at the 3rd World Arthroplasty Congress available.